ArticleBMC infectious diseases2022
Prediction and analysis of COVID-19 daily new cases and cumulative cases: times series forecasting and machine learning models.
Article in BMC infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 74 citations in OpenAlex.
- Comparative Analysis of SARIMA, Prophet, and a Diagnostic Decomposition-Correction Hybrid for Long-Horizon Lottery Sales Forecasting.Entropy (Basel, Switzerland) · 2026Article
- A systems approach for anticipating post-pandemic forecast challenges for pediatric influenza and hospital burden.Scientific reports · 2025Article
- Developing predictive models for COVID-19 positive tests based on the XGBoost and random forest algorithms with internet search data.BMC public health · 2025Article
- Excess and reduced work absence during COVID-19 in Poland: insights from cause-specific time-series models.Population health metrics · 2025Article
- A Forecast Model for COVID-19 Spread Trends Using Blog and GPS Data from Smartphones.Entropy (Basel, Switzerland) · 2025Article
- An investigation into the impact of temporality on COVID-19 infection and mortality predictions: new perspective based on Shapley Values.BMC medical research methodology · 2025Article
- Harnessing artificial intelligence for enhanced public health surveillance: a narrative review.Frontiers in public health · 2025Review
- Temporal dynamics and forecasting of respiratory viral infections during and after the SARS-CoV-2 pandemic (2020-2027): a multiplex PCR and ARIMA-based study.Frontiers in microbiology · 2025Article
- An Interrupted Time Series Analysis of the Impact of the COVID-19 Pandemic on Routine Vaccination Uptake in Kenya.Vaccines · 2024Article
- Simple mathematical model for predicting COVID-19 outbreaks in Japan based on epidemic waves with a cyclical trend.BMC infectious diseases · 2024Article
- A novel hybrid supervised and unsupervised hierarchical ensemble for COVID-19 cases and mortality prediction.Scientific reports · 2024Article
- Time series analysis and short-term forecasting of monkeypox outbreak trends in the 10 major affected countries.BMC infectious diseases · 2024Article
- Enhancing infectious disease prediction model selection with multi-objective optimization: an empirical study.PeerJ. Computer science · 2024Article
- Exploring the influence of environmental indicators and forecasting influenza incidence using ARIMAX models.Frontiers in public health · 2024Article
- Spatial distribution of COVID-19 patients in Sri Lanka.BMC public health · 2023Article
- Estimate the incubation period of coronavirus 2019 (COVID-19).Computers in biology and medicine · 2023Article
- Is It Possible to Predict COVID-19? Stochastic System Dynamic Model of Infection Spread in Kazakhstan.Healthcare (Basel, Switzerland) · 2023Article
- Utility of the Comprehensive Health and Stringency Indexes in Evaluating Government Responses for Containing the Spread of COVID-19 in India: Ecological Time-Series Study.JMIR public health and surveillance · 2023Article
- Dynamic variations in and prediction of COVID-19 with omicron in the four first-tier cities of mainland China, Hong Kong, and Singapore.Frontiers in public health · 2023Article
- Mathematical Models Supporting Control of COVID-19.China CDC weekly · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 1 institution in 1 country.
Funding
Abstract
backgroundCOVID-19 poses a severe threat to global human health, especially the USA, Brazil, and India cases continue to increase dynamically, which has a far-reaching impact on people's health, social activities, and the local economic situation.
methodsThe study proposed the ARIMA, SARIMA and Prophet models to predict daily new cases and cumulative confirmed cases in the USA, Brazil and India over the next 30 days based on the COVID-19 new confirmed cases and cumulative confirmed cases data set(May 1, 2020, and November 30, 2021) published by the official WHO, Three models were implemented in the R 4.1.1 software with forecast and prophet package. The performance of different models was evaluated by using root mean square error (RMSE), mean absolute error (MAE) and mean absolute percentage error (MAPE).
resultsThrough the fitting and prediction of daily new case data, we reveal that the Prophet model has more advantages in the prediction of the COVID-19 of the USA, which could compose data components and capture periodic characteristics when the data changes significantly, while SARIMA is more likely to appear over-fitting in the USA. And the SARIMA model captured a seven-day period hidden in daily COVID-19 new cases from 3 countries. While in the prediction of new cumulative cases, the ARIMA model has a better ability to fit and predict the data with a positive growth trend in different countries(Brazil and India).
conclusionsThis study can shed light on understanding the outbreak trends and give an insight into the epidemiological control of these regions. Further, the prediction of the Prophet model showed sufficient accuracy in the daily COVID-19 new cases of the USA. The ARIMA model is suitable for predicting Brazil and India, which can help take precautions and policy formulation for this epidemic in other countries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.